AIDS-related Burkitt lymphoma in the United States: What do age and CD4 lymphocyte patterns tell us about etiology and/or biology?

Blood

Volumn 116, Issue 25, 2010, Pages 5600-5604

  Guech Ongey, Mercy ^a   Simard, Edgar P ^a   Anderson, William F ^a   Engels, Eric A ^a   Bhatia, Kishor ^a   Devesa, Susan S ^a   Mbulaiteye, Sam M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; UNITED STATES;

EID: 78650438998     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-03-275917     Document Type: Article

References (40)

1. Leoncini L, Raphael M, Stein H, Harris NL, Jaffe ES, Kluin PM, eds. Burkitt lymphoma. 4th ed. Lyon, France: International Agency for Research on Cancer (IARC); 2008.
2. Bornkamm GW. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int J Cancer. 2009;124(8):1745-1755.
3. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer. 2008;123(11):2658-2663.
4. Levine PH, Connelly RR, McKay FW. Burkitt's lymphoma in the USA: cases reported to the American Burkitt Lymphoma Registry compared with population-based incidence and mortality data. IARC Sci Publ. 1985(60):217-224.
5. Mbulaiteye SM, Biggar RJ, Bhatia K, Linet MS, Devesa SS. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer. 2009;53(3):366-370.
6. Amsel S, Nabembezi JS. Two-year survey of hematologic malignancies in Uganda. J Natl Cancer Inst. 1974;52(5):1397-1401.
7. Iversen U, Iversen OH, Bluming AZ, Ziegler JL, Kyalwasi S. Cell kinetics of African cases of Burkitt lymphoma. A preliminary report. Eur J Cancer. 1972;8(3):305-308.
8. Mbulaiteye SM, Anderson WF, Bhatia K, Rosenberg PS, Linet MS, Devesa SS. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer. 2010;126(7):1732-1739.
9. Human immunodeficiency virus (HIV) infection codes. Official authorized addendum. ICD-9-CM (Revision No. 1). Effective January 1, 1988. MMWR Morb Mortal Wkly Rep. 1987;36(suppl 7):1S-20S.
10. Grulich AE. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS. 2009;4(3):183-187.
11. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285(13):1736-1745. (Pubitemid 32259908)
12. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351(9119):1833-1839.
13. Jaro MA. Probabilistic linkage of large public health data files. Stat Med. 14(5-7):491-498, 1995.
14. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20(12):1645-1654.
15. Cote TR, O'Brien TR, Ward JW, Wilson SE, Blattner WA. AIDS and cancer registry linkage: measurement and enhancement of registry completeness. The National AIDS/Cancer Match Study Group. Prev Med. 1995;24(4):375-377.
16. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology (ICD-O-3). 3rd ed. Geneva, Switzerland:World Health Organization; 2000.
17. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol. 1995;141(4):300-304.
18. Ries LAG, Devesa SS. Cancer incidence, mortality, and patient survival in the United States. In: Schottenfeld D, Fraumeni J Jr, eds. Cancer Epidemiology and Prevention. 3rd Ed. New York, NY: Oxford University Press; 2006:139-167.
19. Jaffe ES, Diebold J, Harris NL, Muller-Hermelink HK, Flandrin G, Vardiman JW. Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Blood. 1999;93(3):1124.
20. Macmahon B. Epidemiological evidence of the nature of Hodgkin's disease. Cancer. 1957;10(5):1045-1054.
21. Wright DH. What is Burkitt's lymphoma and when is it endemic? Blood. 1999;93(2):758.
22. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Geneva, Switzerland: World Health Organization; 2008.
23. Carbone PP, Berard CW, Bennett JM, Ziegler JL, Cohen MH, Gerber P. NIH clinical staff conference. Burkitt's tumor. Ann Intern Med. 1969;70(4):817-832.
24. Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer. 2009;124(7):1497-1502.
25. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99(12):962-972.
26. Ferry JA. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist. 2006;11(4):375-383.
27. Gabarre J, Raphael M, Lepage E, et al. Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes. Am J Med. 2001;111(9):704-711. (Pubitemid 34017522)
28. Pluda JM, Venzon DJ, Tosato G, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol. 1993;11(6):1099-1107. (Pubitemid 23163350)
29. Epidemiology of HIV/AIDS - United States, 1981-2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):589-592.
30. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol. 2005;3(2):182-187. (Pubitemid 40207598)
31. Bhatia K, Magrath I. Pathogenesis of small noncleaved cell lymphoma (Burkitt's lymphoma). In: Magrath I, ed. The Non Non-Hodgkin's Lymphomas. 2nd ed. London, United Kingdom: Arnold; 1997;402-404.
32. Klein G. Burkitt lymphoma-A stalking horse for cancer research? Semin Cancer Biol. 2009;19(6):347-350.
33. Manolov G, Manolova Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature. 1972;237(5349):33-34.
34. Muramatsu M, Sankaranand VS, Anant S, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999;274(26):18470- 18476. (Pubitemid 129519249)
35. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity. 2007;27(2):190-202.
36. Epeldegui M, Breen EC, Hung YP, Boscardin WJ, Detels R, Martinez-Maza O. Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis. AIDS. 2007;21(17):2265-2270. (Pubitemid 350287452)
37. Muller JR, Janz S, Goedert JJ, Potter M, Rabkin CS. Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sci U S A. 1995;92(14):6577-6581.
38. Levesque MC, Moody MA, Hwang KK, et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med. 2009;6(7):e1000107.
39. Pantaleo G, Graziosi C, Butini L, et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U SA. 1991;88(21):9838-9842. (Pubitemid 21915729)
40. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993;362(6418):355-358. (Pubitemid 23101310)